PHARMACEUTICAL COMPOSITION FOR TREATING CYTOSTATIC MYELOSUPPRESSION Russian patent published in 2013 - IPC A61K31/721 A61K47/30 A61K9/127 A61P7/00 B82B1/00 B82Y5/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a pharmaceutical composition for treating cytostatic myelosuppression. The declared composition containing 0.4-4 wt % of oxidised dextran of molecular weight 35-70 kDa as a leukopoiesis stimulator, a liposome-forming agent - phosphatidyl choline in the amount of 1.0-4.0 wt %, a liposome stabiliser representing polyethylene glycol of molecular weight 1500-4000 Da in the amount of 0.4-4 wt % and a pharmaceutically acceptable excipient. The pharmaceutical composition may be presented in the form of a nanoliposome emulsion of liposome size 150-800 nm.

EFFECT: invention provides preparing the pharmaceutical composition for more effective and earlier prevention of cytostatic myelosuppression.

3 cl, 1 tbl, 3 ex